Using a highly toxic cancer drug called vorinostat, researchers have been able to control how HIV genes are turned on and off, therefore giving them the opportunity to bring the virus out of hiding and better control it
Sectors - Health Care
Australian researchers are developing an early detection blood test that could significantly increase the survival rate of ovarian cancer patients; currently, just 20 per cent of patients survive beyond five years
Australia becomes the first country in the world to provide the HPV vaccine to teenage boys through a $21 million program
A deadly bout of influenza affecting at least 47 states in the US could make its way to Australia
Twitter's rumoured office expansion onto Australian soil would help reduce the nation's cyberbullying problem by "streamlining cooperation with authorities" to identify online "trolls," says mental health organisation beyondblue
The free app connects users to the National Health Services Directory and provides the contact information and opening times of these health services, as well as directions there via Google Maps
A 70 per cent cut price cut for Docetaxel, a well known chemotherapy medication, has Queensland and Victoria's health practitioners and pharmacists concerned over the costs that will impact private chemotherapy services, hospitals and patients
A recent survey has suggested that Australian workers could be owed as much as a weeks holiday per year for the time missed whilst eating lunch at their desks, or skipping lunch al together
The Australian government has expressed frustration at attempts by large tobacco companies to mock new packaging laws
ANZ residents consume more marijuana per capita than any other country
Those who indulge in a morning long black may enjoy a longer life
A work-life balance study conducted by HR company NorthgateArinso found that only 38 per cent of Aussies now check their work email outside the office and 24 per cent initiating work-related phone calls - both significantly lower figures than last year's study results revealed
Generic pharmaceuticals may be raking in high dollars for global drug manufacturers, but at the same time, they're endangering patients' health with the prospect of users having to switch between multiple brands
Through diet and exercise, Australia can prevent 43,000 cancer cases and save AU$674 million by 2025
A new the study published in the Journal of the National Cancer Institute compared cell phone usage of a group of children and adolescents finds there's no link to brain tumours
Therapeutics Good Association approved the melanoma-fighting drug Yervoy on Friday, hoping that it will add two years to melanoma patients
Written by Elissa Miller, ResMed Sleep apnea, a common but little-known disorder, affects 1 in 5 adults. It stems from closure of the airway during sleep which causes breathing to stop -- sometimes for more than a minute...
Qiagen lodges A$341 million takeover bid for Cellestis for $3.55 per share to acquire tuberculosis technology
Despite reporting a full-year loss of $235.4 million, Sigma Pharmaceuticals shares rose more than 10 percent to 46 cents Monday.
NAB’s CEO Lynne Peacock is reported to have put the acquisition of 600 bank branches from Lloyds Banking Group as a company priori
Australian businesses with existing paid parental leave arrangements in place are unlikely to decrease the entitlements following the introduction of Federal Government’s new paid parental scheme, global consulting firm Mercer found. The new government scheme allows primary caregivers for...
U2 frontman Bono was in Sydney Wednesday to honor World AIDS Day, lighting the Sydney Opera House and Harbour Bridge red to commemorate the international occasion.
Things are looking up for Eli Lilly and Co. and Acrux—the US Food and Drug Administration (FDA) has just approved their testosterone topical solution. Axiron, a replacement therapy for men with low testosterone levels, is the first testosterone topical solution...
Swiss-based healthcare researcher Roche is effectively testing new drugs that can shrink melanoma tumors. The results from a clinical study of RG7204 showed that the BRAF inhibitor RG7204 shrank tumors in more than half of people with previously treated...
Australian pathology provider Sonic Healthcare reported an annual net profit A$293 million, down from 2009 due to market effects of regulatory changes in Australia.
Sigma Pharmaceuticals announced Monday that Aspen Pharmacare will buy its Pharmaceuticals Division, comprised of its generic and over-the-counter drugs portfolio, Herron and Orphan brands and manufacturing businesses, for A$900 million. Under the proposed terms Sigma will retain its Healthcare...
ASX-listed ear implant maker Cochlear announced that its total profits for fiscal year 2010 were $155.2 million, up nineteen percent. Total revenues were $734.8 million, up six percent. In a statement from Cochlear, CEO and President Dr. Chris Roberts...
Dually-listed sleep apnoea device maker ResMed Inc. reported revenue for the quarter ending June 30 was $291.6 million, a 16 percent increase from the same period last year. Income from operations was $68.6 million and net income was $53.2...
Melbourne-based hospital operator Healthscope announced Monday that today that it has entered into an agreement with The Carlyle Group and TPG Capital for the acquisition of all of its shares for A$6.26 per share, valuing Healthscope at approximately $2.7 billion.
Australian generic drug maker and distributor Sigma Pharmaceuticals Limited announced Thursday that it is has received a formal proposal to acquire all of the issued share capital at A$0.55 per share from South African-based Aspen Pharmacare at an equity...
US healthcare services provider Tenet Healthcare Corporation announced Tuesday that it has engaged in preliminary discussions to acquire Australian hospital operator Healthscope for $1.84 billion. In a release from Tenet to the US market, the company said, “Healthscope owns...